Articles related to KIDNEY DISEASE

The approval of empagliflozin opens up a new avenue in CKD treatment. With its proven efficacy in reducing the risk of disease progression by 28%, it offers a promising alternative for healthcare professionals dealing with this prevalent condition.

Explore this comprehensive guide on evaluating a low anion gap and enhance your diagnostic capabilities. Don’t miss out on the opportunity to learn more.

Medication Prescribing Error: A Medical Malpractice Case with Tragic Consequences In an evolving healthcare ecosystem, the need for rigorous medication dosing protocols based on patient-specific conditions is underlined in a recent medical malpractice case involving a nurse practitioner and an unfortunate prescription error.

Advancing kidney health. Nanoscience. Bioanalytics. Biomaterials. Fighting pediatric leukemias. What’s the common thread? They describe the areas of research focus for four electees to AAAS this year.

At the 2023 HIMSS meeting, Dr. Sandra Kane-Gill discussed a new alert system being developed at UPMC to improve care for patients at risk for drug-associated acute kidney injury (AKI). According to Dr. Kane-Gill, drugs are involved in approximately 30% of AKI cases in hospitalized patients, but imprecise alert systems mean that at-risk patients could be overlooked. To address this challenge, Dr. Kane-Gill led a consensus-building project to identify 20 drugs that are probably or definitely nephrotoxic with routine use. UPMC has developed a prototype alert tool for AKI that uses this list of nephrotoxic drugs to accurately detect AKI in patients. Preliminary results indicate that for every five alerts generated, there was one case of drug-associated AKI, a higher accuracy rate than for other alert systems. Dr. Kane-Gill plans to further refine the alert tool before deploying it in practice at UPMC and is also interested in using machine learning to prevent episodes of kidney injury.

A young woman with progressive autosomal dominant PKD is seen for follow up. She had a recent infected kidney cyst. Except for a palpable right kidney, the exam is unremarkable. Labs show a decrease in eGFR from a year prior. She is on lisinopril. What is your approach to treatment now?